Exemestane

Product NDC
47781-108
Requested package NDC
47781-108-30
11-digit product format
477810108
Labeler code
47781
Product ID
47781-108_4e82185c-b69a-d9dc-954c-d7765a720bb6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Exemestane
Dosage form
TABLET
Route
ORAL
Labeler
Alvogen Inc.
Application
ANDA200898
Marketing category
ANDA
Marketing start
2014-07-25
Marketing end
2022-12-01
Substance
EXEMESTANE
Active strength
25 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage47781-10847781-108-30DDiscontinued by firm2026-11-19

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A200898-001EXEMESTANEEXEMESTANE25MGTABLET / ORALAB2014-07-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A200898-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-28d4dbc9d85df4…
2026-10-15 13:18:302026-09A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28c2088c7a36db…
2026-09-14 22:38:342026-08A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-2884e616aacf4f…
2026-08-18 06:07:402026-07A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-283f01610625f2…
2019-09-15 20:21 UTC2019-09A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A200898-001EXEMESTANE25MGTABLET / ORAL2014-07-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A200898-001EXEMESTANE25MGTABLET / ORALAB2014-07-283bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A200898-001AB1d4dbc9d85df4…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A200898-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A200898-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A200898-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A200898-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A200898-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A200898-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A200898-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A200898-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A200898-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A200898-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A200898-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A200898-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A200898-001AB1ea99ee380514…
2023-01-26 05:58 UTC2023-01A200898-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A200898-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A200898-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A200898-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A200898-001AB1cb3db0bc1861…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1fe6d34b-d50f-eeb9-bd0c-3f0d6b635985Product name920230126
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
47781-108-30EA - Each47781-1084d3b58cb-940e-4595-9836-bcbcc08cc66512014-08-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
EXEMESTANEACTIVE INGREDIENTNY22HMQ4BXEXEMESTANE TABLET [ALVOGEN INC. ]1
EXEMESTANEACTIVE MOIETYNY22HMQ4BXEXEMESTANE TABLET [ALVOGEN INC. ]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UEXEMESTANE TABLET [ALVOGEN INC. ]1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BEXEMESTANE TABLET [ALVOGEN INC. ]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKEXEMESTANE TABLET [ALVOGEN INC. ]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOEXEMESTANE TABLET [ALVOGEN INC. ]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30EXEMESTANE TABLET [ALVOGEN INC. ]1
MANNITOLINACTIVE INGREDIENT3OWL53L36AEXEMESTANE TABLET [ALVOGEN INC. ]1
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AEXEMESTANE TABLET [ALVOGEN INC. ]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2EXEMESTANE TABLET [ALVOGEN INC. ]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPEXEMESTANE TABLET [ALVOGEN INC. ]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EXEMESTANEEXEMESTANEOPKO Pharmaceuticals, LLC392b5b4f-3fb4-4ba7-a15a-6022298db7192026-10-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 200898
application number: ANDA200898

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310261exemestane 25 MG Oral TabletPSN15e11379-e681-4f2b-bdd6-dbbe56e563b04
310261exemestane 25 MG Oral TabletSCD15e11379-e681-4f2b-bdd6-dbbe56e563b04

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
47781-108-304778101083030 TABLET in 1 BOTTLE (47781-108-30) 30 tablet2014-07-252022-12-01NoNoCurrent